Evidence map›Paper›PMID 36982672›Full record

ArticleInternational journal of molecular sciences2023

NAADP-Evoked Ca

Cássia Arruda de Souza Pereira, Natalia de Castro Medaglia, Rodrigo Portes Ureshino, Claudia Bincoletto, Manuela Antonioli, Gian Maria Fimia, Mauro Piacentini, Gustavo José da Silva Pereira, Adolfo Garcia Erustes, Soraya Soubhi Smaili

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. The CaInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Neurodegenerative Disease: From Molecular Basis to Therapy.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Cássia Arruda de Souza PereiraDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.
Natalia de Castro MedagliaDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.
Rodrigo Portes UreshinoInstituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema 09913-030, Brazil.ORCID 0000-0003-3371-3376
Claudia BincolettoDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.ORCID 0000-0001-6666-3673
Manuela AntonioliDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS "L. Spallanzani", 00149 Rome, Italy.ORCID 0000-0002-7568-4713
Gian Maria FimiaDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS "L. Spallanzani", 00149 Rome, Italy.ORCID 0000-0003-4438-3325
Mauro PiacentiniDepartment of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases IRCCS "L. Spallanzani", 00149 Rome, Italy.
Gustavo José da Silva PereiraDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.ORCID 0000-0002-6765-1276
Adolfo Garcia ErustesDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.ORCID 0000-0002-1903-4150
Soraya Soubhi SmailiDepartament of Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo 04044-020, Brazil.ORCID 0000-0001-5844-1368
Universidade Federal de São Paulo · BRUniversity of Rome Tor Vergata · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior code 001São Paulo Research Foundation 2016/20796-2São Paulo Research Foundation 2017/10863-7São Paulo Research Foundation 2019/02921-8São Paulo Research Foundation 2019/14722-4São Paulo Research Foundation 2020/08840-1
6 · The paper itself

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disease characterized by mutations in the huntingtin gene (mHtt), causing an unstable repeat of the CAG trinucleotide, leading to abnormal long repeats of polyglutamine (poly-Q) in the N-terminal region of the huntingtin, which form abnormal conformations and aggregates. Alterations in Ca

Indexed as

Calcium ChannelsNeurodegenerative DiseasesAnimalsAstrocytesAutophagyCalciumHuntingtin ProteinLysosomesMiceNADPCalciumCalcium ChannelsHuntingtin ProteinNAADPNADPHuntington’s diseaselysosomeNAADPtwo-pore channels

Identifiers

PMID36982672
PMCPMC10058390
OpenAlexW4324382680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.